Drugs / oral liposomal iron
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02760940 | Aug 2016 → Aug 2017 | anemia, inflammatory bowel disease | Federal University of Juiz de Fora | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | oral liposomal iron | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02760940 ↗ |
| Route | Oral | “Patients with mild and moderate anemia in remission will be initially treated with oral iron (oral liposomal iron)” NCT02760940 ↗ |